ReviewCancer drug resistance (Alhambra, Calif.)2024

Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma.

Anum Jalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.